Peptides in Skincare: What Matrixyl, Argireline and Copper Peptide Trials Show

Peptides in skincare are short chains of amino acids added to creams and serums to make wrinkles less visible. A few have small controlled trials showing modest improvements in fine lines, mostly run or paid for by the companies that sell them.^[5][10] Copper peptide, the one most promoted alongside GLP-1 treatment, was no better than skincare without it on objective measures in its one published randomized skin trial.^[11] Two of the three most common are also larger than the size that normally gets through skin.^[4] Sold as cosmetics, none of them needs FDA approval, and none may legally claim to rebuild collagen.^[1][2]

What a skincare peptide is supposed to do

Cosmetic peptides fall into a few groups by the job their makers claim for them. “Signal” peptides are said to tell skin cells to make more collagen. “Neurotransmitter-inhibiting” peptides are said to relax the small muscles that crease the skin, which is why one is sold as a topical alternative to Botox. “Carrier” peptides deliver a metal such as copper into the skin. The ingredient names on a label are standardized cosmetic names; the trademarks are what get marketed.

Sizes are molecular weights from PubChem. The comparison that matters is the 500-dalton rule: dermatologists have long observed that compounds much above about 500 daltons do not cross the outer layer of skin well, which is why nearly every topical drug is smaller than that.^[4] Two of the three most common peptides are well over that limit.

Palmitoyl pentapeptide-4 (Matrixyl)

This is five amino acids, lysine-threonine-threonine-lysine-serine, with a fatty palmitoyl chain attached. In the main trial, 93 women aged 35 to 55 used an ordinary moisturizer on one side of the face and the same moisturizer with 3 parts per million of the peptide on the other, for 12 weeks. The peptide side showed significantly fewer wrinkles and fine lines on image analysis and expert grading, and the women themselves rated it better.^[5] The study came from Procter & Gamble’s laboratories.^[5]

A larger Procter & Gamble trial tested a full regimen rather than the peptide alone. In 196 women with moderate wrinkles around the eyes, a set of products containing niacinamide, peptides and retinyl propionate improved wrinkle appearance more than prescription 0.02% tretinoin at eight weeks, with comparable results at 24 weeks in the smaller group that continued, and caused less irritation.^[10] Procter & Gamble funded the trial, five authors were its employees and the other six were its paid consultants.^[10] Because the products held three active ingredients, the trial cannot say how much the peptide contributed.

Acetyl hexapeptide-8 (Argireline)

Argireline came out of a design program at a university in Alicante, Spain, that set out to find a non-toxic molecule acting like botulinum toxin. In lab tests it interfered with the protein complex nerve endings need to release their signal, with a potency similar to the toxin’s but much lower efficacy. In the first report, an emulsion described as containing 10% of the hexapeptide reduced wrinkle depth by up to 30% after 30 days in healthy women, with no placebo comparison reported.^[6] A later Chinese trial randomized 60 people three to one to argireline or placebo around the eyes for four weeks and reported a significant reduction in wrinkle depth.^[7]

Whether the peptide reaches the facial muscles at all is unsettled. A 2025 review noted that argireline is water-loving and large, passes poorly through the skin’s fatty outer layer, and that its ability to reach the nerve-muscle junction remains uncertain.^[8] The Expert Panel for Cosmetic Ingredient Safety concluded in 2025 that it is safe in cosmetics at concentrations up to 0.005% and that the data were insufficient to judge it safe at higher concentrations.^[9]

Copper peptide (GHK-Cu)

GHK-Cu is the skincare peptide most often sold to people on GLP-1 drugs, in serums and in injectable “Glow” blends from telehealth clinics. It is the smallest of the three, but it dissolves readily in water, and in a lab test on donated human skin almost no peptide or copper crossed intact skin.^[13] The one randomized skin trial in a journal treated 13 patients after laser resurfacing around the mouth: evaluators found no objective improvement in wrinkles or skin quality with GHK-Cu, although patients using it were more satisfied.^[11] A 2025 review of GHK as an anti-wrinkle ingredient described “a surprising absence of clinical studies.”^[12] The full record, including the injected form, is in GHK-Cu: what the evidence shows, its hair claims in peptides for hair growth, and who sells it is on the GHK-Cu page.

How peptides compare with what dermatologists rely on

A 2021 systematic review of over-the-counter anti-aging ingredients by Zurich dermatologists noted that, despite the huge range of products for sale, the evidence supporting their use is often lacking.^[14] Prescription tretinoin is the benchmark against which cosmetic regimens are measured, which is why the Procter & Gamble trial chose it as the comparator.^[10] The peptide trials are small, short and largely company-run, and none has tested a peptide alone against tretinoin.

Much of the facial change people notice during major weight loss is lost volume rather than surface wrinkling, and no cosmetic peptide has been tested for that. The skin effects people ask about most on these drugs are collected in our skin changes Q&A, and rashes and tenderness in skin sensitivity on a GLP-1.

Cosmetic or drug: the line FDA draws

Whether a skin product is a cosmetic or a drug depends on its intended use, as shown by its claims.^[1] FDA’s anti-aging guidance draws the line plainly: a product meant to make lines less noticeable by moisturizing the skin is a cosmetic, but one meant to remove wrinkles or increase the skin’s production of collagen is a drug or a medical device.^[2] Drugs need FDA approval for safety and effectiveness before sale. Cosmetics and their ingredients, apart from color additives, do not.^[1]

That is why peptide serums say they “reduce the appearance of” wrinkles rather than that they build collagen. Since the Modernization of Cosmetics Regulation Act, the company responsible for a cosmetic must keep records showing it is safe and must report serious adverse events to FDA within 15 business days, but no specific safety tests are required and there is still no premarket review.^[3] Peptides sold as injections are a different category entirely: they are drugs, and their status is set out in are peptides legal.